Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 59fludarabine phosphate 42Peripheral Blood Stem Cell Transplantation 33Cyclosporine 32Busulfan 32Radiotherapy 30Mycophenolic Acid 30Filgrastim 30Antilymphocyte Serum 28Whole-Body Irradiation 26Melphalan 21Methylprednisolone 19Methotrexate 19Etoposide 19Tacrolimus 17Cord Blood Stem Cell Transplantation 17Cytarabine 10Thiotepa 9fludarabine 6aldesleukin 6sargramostim 5Vincristine 5Sirolimus 5Rituximab 5Psychiatric Rehabilitation 5Granulocyte Colony-Stimulating Factor 5Therapeutics 4Prednisone 4Doxorubicin 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × ocaratuzumab × Other hematologic neoplasm × Clear all
NCT00003874 2011-11-29

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Fred Hutchinson Cancer Center

Phase 1/2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡